Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Cited In for PubMed (Select 8094166)

1.

An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids.

Wu L, Sun W, Wang B, Zhao H, Li Y, Cai S, Xiang L, Zhu Y, Yao H, Song J, Cheng YC, Chen S.

Sci Rep. 2015 Aug 13;5:11318. doi: 10.1038/srep11318.

2.

Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.

Wang K, Feng C, Li C, Yao J, Xie X, Gong L, Luan Y, Xing G, Zhu X, Qi X, Ren J.

Int J Mol Sci. 2015 Jul 20;16(7):16454-68. doi: 10.3390/ijms160716454.

3.

Acute Renal Failure Induced by Chinese Herbal Medication in Nigeria.

Akpan EE, Ekrikpo UE.

Case Rep Med. 2015;2015:150204. doi: 10.1155/2015/150204. Epub 2015 Jun 25.

4.

Computational Optimization of Bioanalytical Parameters for the Evaluation of the Toxicity of the Phytomarker 1,4 Napthoquinone and its Metabolite 1,2,4-trihydroxynapththalene.

Gopal V, Al Rashid MH, Majumder S, Maiti PP, Mandal SC.

J Pharmacopuncture. 2015 Jun;18(2):7-18. doi: 10.3831/KPI.2015.18.010.

5.

Balkan endemic nephropathy-current status and future perspectives.

Pavlović NM.

Clin Kidney J. 2013 Jun;6(3):257-65. doi: 10.1093/ckj/sft049. Review.

6.

Smad7 protects against chronic aristolochic acid nephropathy in mice.

Dai XY, Zhou L, Huang XR, Fu P, Lan HY.

Oncotarget. 2015 May 20;6(14):11930-44.

7.

CKD hotspots around the world: where, why and what the lessons are. A CKJ review series.

Martín-Cleary C, Ortiz A.

Clin Kidney J. 2014 Dec;7(6):519-23. doi: 10.1093/ckj/sfu118. Epub 2014 Nov 13.

8.

Enhanced evidence-based chinese medicine clinical practice guidelines in Hong Kong: a study protocol for three common diseases.

Shi N, Zhong LL, Han X, Ziea TC, Ng B, Bian Z, Lu A.

Evid Based Complement Alternat Med. 2015;2015:482706. doi: 10.1155/2015/482706. Epub 2015 Mar 1.

9.

Can Herbal Medicine Cause Hematoma Enlargement of Hypertensive Intracerebral Hemorrhage within 24 hrs Time Window? A Retrospective Study of 256 Cases from a Single Center in China.

Xu Y, Guo J, Liu X, Li J, Wang J, Hou L.

Evid Based Complement Alternat Med. 2015;2015:868731. doi: 10.1155/2015/868731. Epub 2015 Feb 19.

10.

Safety surveillance of traditional Chinese medicine: current and future.

Liu SH, Chuang WC, Lam W, Jiang Z, Cheng YC.

Drug Saf. 2015 Feb;38(2):117-28. doi: 10.1007/s40264-014-0250-z.

PMID:
25647717
11.

Preventing aristolochic acid nephropathy.

Anandagoda N, Lord GM.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):167-8. doi: 10.2215/CJN.12391214. Epub 2015 Jan 13. No abstract available.

PMID:
25587104
12.

Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants.

Jelaković B, Vuković Lela I, Karanović S, Dika Ž, Kos J, Dickman K, Šekoranja M, Poljičanin T, Mišić M, Premužić V, Abramović M, Matijević V, Miletić Medved M, Cvitković A, Edwards K, Fuček M, Leko N, Teskera T, Laganović M, Čvorišćec D, Grollman AP.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):215-23. doi: 10.2215/CJN.03190314. Epub 2015 Jan 13.

PMID:
25587102
13.
14.

Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissection.

Aydin S, Dekairelle AF, Ambroise J, Durant JF, Heusterspreute M, Guiot Y, Cosyns JP, Gala JL.

PLoS One. 2014 Sep 3;9(9):e106301. doi: 10.1371/journal.pone.0106301. eCollection 2014.

15.

Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.

Wang LJ, Lee SY, Teh BT, Chuang CK, Nortier J.

Biomed Res Int. 2014;2014:989458. doi: 10.1155/2014/989458. Epub 2014 Aug 7. Review.

16.

Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.

Wang SM, Lai MN, Wei A, Chen YY, Pu YS, Chen PC, Wang JD.

PLoS One. 2014 Aug 29;9(8):e105218. doi: 10.1371/journal.pone.0105218. eCollection 2014.

17.

Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention.

Poon SL, McPherson JR, Tan P, Teh BT, Rozen SG.

Genome Med. 2014 Mar 31;6(3):24. doi: 10.1186/gm541. eCollection 2014. Review.

18.

Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.

Bui-Klimke T, Wu F.

Risk Anal. 2014 Sep;34(9):1688-705. doi: 10.1111/risa.12239. Epub 2014 Jun 20.

PMID:
24954501
19.

Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches.

Stiborová M, Frei E, Schmeiser HH, Arlt VM, Martínek V.

Int J Mol Sci. 2014 Jun 10;15(6):10271-95. doi: 10.3390/ijms150610271. Review.

20.

Total synthesis of the aristolochic acids, their major metabolites, and related compounds.

Attaluri S, Iden CR, Bonala RR, Johnson F.

Chem Res Toxicol. 2014 Jul 21;27(7):1236-42. doi: 10.1021/tx500122x. Epub 2014 Jun 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk